bellvei.cat

Merck

4.6 (396) · $ 12.00 · In stock

At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.

Merck Doubles Down on Biologics, Closing Plants and Cutting Jobs

Merck is fighting Inflation Reduction Act in court, lobbying

Merck's diabetes drug highlights debate over U.S. patent system

Merck Family Fund

Merck's $680M Harpoon acquisition to diversify oncology pipeline

Merck Partners With Vector Institute To Advance AI In Healthcare

Merck drug for rare cardiovascular condition approved in U.S.

Merck : Quotes, Address, Contact

Q1 Results: Merck Benefits from Global Diversification in a Challenging Environment - Medium-term structural growth drivers intact

Merck to Acquire Caraway Therapeutics, Inc. - Caraway Therapeutics

Merck is on the lookout for more opportunities within immunology - Pharmaceutical Technology

Merck Animal Health (@MerckAH) / X

Merck Asks F.D.A. for Emergency Approval of Covid Pill - The New York Times